Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

804 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Potential of Antiviral Peptides as COVID-19 Therapeutics.
Mahendran ASK, Lim YS, Fang CM, Loh HS, Le CF. Mahendran ASK, et al. Among authors: lim ys. Front Pharmacol. 2020 Sep 15;11:575444. doi: 10.3389/fphar.2020.575444. eCollection 2020. Front Pharmacol. 2020. PMID: 33041819 Free PMC article. No abstract available.
Proteomics in commercial crops: An overview.
Tan BC, Lim YS, Lau SE. Tan BC, et al. Among authors: lim ys. J Proteomics. 2017 Oct 3;169:176-188. doi: 10.1016/j.jprot.2017.05.018. Epub 2017 May 22. J Proteomics. 2017. PMID: 28546092 Review.
Adjunctive pascolizumab in rifampicin-susceptible pulmonary tuberculosis: proof-of-concept, partially-randomised, double-blind, placebo-controlled, dose-escalation trial.
Paton NI, Gurumurthy M, Lu Q, Leek F, Kwan P, Koh HWL, Molton J, Mortera L, Naval S, Abu Bakar Z, Pang YK, Lum L, Lim TK, Cross GB, Lekurwale G, Choi H, Au V, Connolly J, Hibberd M, Green JA; Pascolizumab Tuberculosis Trial Team. Paton NI, et al. J Infect Dis. 2024 Mar 25:jiae104. doi: 10.1093/infdis/jiae104. Online ahead of print. J Infect Dis. 2024. PMID: 38527849
804 results